Bio-Rad Laboratories (BIO-B) Cash & Equivalents Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.51% |
| Dec 31, 2025 | -4.36% |
| Sep 30, 2025 | -13.98% |
| Jun 30, 2025 | -9.48% |
| Mar 31, 2025 | -2.88% |
| Dec 31, 2024 | -5.88% |
| Sep 30, 2024 | -6.06% |
| Jun 30, 2024 | -6.87% |
| Mar 31, 2024 | -1.01% |
| Dec 31, 2023 | -1.32% |
| Sep 30, 2023 | 1.05% |
| Jun 30, 2023 | -0.65% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | 2.50% |
| Sep 30, 2022 | 9.51% |
| Jun 30, 2022 | 13.16% |
| Mar 31, 2022 | 22.43% |
| Dec 31, 2021 | 0.63% |
| Sep 30, 2021 | 15.52% |
| Jun 30, 2021 | 11.85% |
| Mar 31, 2021 | 9.97% |
| Dec 31, 2020 | 7.67% |
| Sep 30, 2020 | 10.62% |
| Jun 30, 2020 | 6.18% |
| Mar 31, 2020 | 7.23% |
| Dec 31, 2019 | 9.84% |
| Sep 30, 2019 | 5.73% |
| Jun 30, 2019 | 8.59% |
| Mar 31, 2019 | 4.58% |
| Dec 31, 2018 | 5.41% |
| Sep 30, 2018 | 8.29% |
| Jun 30, 2018 | 1.89% |
| Mar 31, 2018 | 2.01% |
| Dec 31, 2017 | -3.70% |
| Sep 30, 2017 | -5.06% |
| Jun 30, 2017 | -6.77% |
| Mar 31, 2017 | -11.39% |
| Dec 31, 2016 | -4.50% |
| Sep 30, 2016 | -9.03% |
| Jun 30, 2016 | -8.98% |
| Mar 31, 2016 | -7.79% |
| Dec 31, 2015 | -12.78% |
| Sep 30, 2015 | -4.26% |
| Jun 30, 2015 | -6.03% |
| Mar 31, 2015 | -6.57% |
| Dec 31, 2014 | -8.66% |
| Sep 30, 2014 | -5.19% |
| Jun 30, 2014 | -6.33% |